Be Biopharma

Last updated: October 11, 2024

Joanne Smith-Farrell, CEO
Joanne Smith-Farrell, CEO
USA | Funding: $182M (+)

Website: https://www.be.bio/

Be Biopharma engineers B-cell therapies. The applications of B cells include everything from autoimmune diseases to cancer and monogenic disorders, which are caused by variation in a single gene.